<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> <z:chebi fb="0" ids="29425">(SCN)</z:chebi> is characterized by low blood neutrophil counts, early <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, and risk of <z:mpath ids='MPATH_336'>leukaemia</z:mpath> development </plain></SENT>
<SENT sid="1" pm="."><plain>As yet, no population-based incidence estimates of <z:chebi fb="0" ids="18022">SCN</z:chebi> have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>Children less than 16 years of age with <z:chebi fb="0" ids="18022">SCN</z:chebi> were sought in Sweden during the 20-year period 1987-2006 by a questionnaire to <z:hpo ids='HP_0000001'>all</z:hpo> Swedish Departments of Paediatrics and by reviewing the Swedish Health and Welfare Statistical Databases </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-two patients were diagnosed with <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> during this period </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> received treatment with recombinant granulocyte-colony stimulating factor (G-CSF) </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-one patients were diagnosed as <z:chebi fb="0" ids="18022">SCN</z:chebi> or probable <z:chebi fb="0" ids="18022">SCN</z:chebi>, corresponding to 1Â·0 per 100,000 live births </plain></SENT>
<SENT sid="6" pm="."><plain>Nine (43%) had ELANE mutations, four (19%) HAX1 mutations and eight (38%) were children with disease of unknown genetic aetiology </plain></SENT>
<SENT sid="7" pm="."><plain>Four out of 21 patients (19%) developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> and three (14%) died, <z:hpo ids='HP_0000001'>all</z:hpo> with <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>The cumulative incidence of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> was 31% </plain></SENT>
<SENT sid="9" pm="."><plain>The observed incidence of <z:chebi fb="0" ids="18022">SCN</z:chebi> in this population-based study was higher than previously estimated, possibly because genetic testing now can identify <z:chebi fb="0" ids="18022">SCN</z:chebi> cases previously thought to be idiopathic or benign <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The risk of developing <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> is considerable </plain></SENT>
<SENT sid="11" pm="."><plain>ELANE mutations are the most commonly identified genetic defects </plain></SENT>
</text></document>